🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jie Na

Mayo Clinic in Florida

ORCID: 0000-0003-3435-1805
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.7Author DataRank

Indexed papers

5in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa023
Top 7%
3.2DataRank
Top 7%108 citations

Eric C. Polley, Siddhartha Yadav, Jenna Lilyquist, Hermela Shimelis, Jie Na +8 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort”.

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa023
Top 7%
3.2DataRank
Top 7%108 citations

Eric C. Polley, Siddhartha Yadav, Jenna Lilyquist, Hermela Shimelis, Jie Na +8 more

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

JCI Insight(2020)10.1172/jci.insight.137571
N/A
1.3DataRank · unranked
45 citations

James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na +12 more

A Population-Based Study of Genes Previously Implicated in Breast Cancer

New England Journal of Medicine(2021)10.1056/nejmoa2005936
N/A
1.0DataRank · unranked
884 citations

Steven N. Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y. Lee, Jie Na +55 more

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190
N/A
0.709DataRank · unranked
112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa040
N/A
0.657DataRank · unranked
79 citations

Eric C. Polley, Chunling Hu, Esther M. John, Christopher A. Haiman, Steven N. Hart +27 more

Functional evaluation and clinical classification of BRCA2 variants

Nature(2025)10.1038/s41586-024-08388-8
N/A
0.606DataRank · unranked
56 citations

Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu, Mohamed Abozaid +39 more

Characterizing phenotypic abnormalities associated with high-risk individuals developing lung cancer using electronic health records from the All of Us researcher workbench

Journal of the American Medical Informatics Association(2021)10.1093/jamia/ocab174
Top 36%
0.543DataRank
Top 36%9 citations

Nansu Zong, Chen Wang, David E. Midthun, Yuan Luo, Ping Yang +2 more

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0594
N/A
0.408DataRank · unranked
8 citations

Nicholas Boddicker, Siddhartha Yadav, Hongyan Huang, Jie Na, Chunling Hu +30 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants

Research Square(2023)10.21203/rs.3.rs-3736200/v1
N/A
0DataRank · unranked
0 citations

Huaizhi Huang, Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu +18 more

Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.02.002
N/A
0DataRank · unranked
17 citations

Huaizhi Huang, Jie Na, Carolyn A. Lumby, Mohamed Abozaid, Megan Holdren +21 more

Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1884
N/A
0DataRank · unranked
11 citations

Ronan E. Couch, Rachid Karam, Chunling Hu, Nicholas Boddicker, Eric C. Polley +37 more

Data Supplement 1 from Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast

Figshare(2025)10.1158/1078-0432.28141741
Top 100%
0DataRank
Top 100%0 citations

Ronan E. Couch, Rachid Karam, Chunling Hu, Nicholas Boddicker, Eric C. Polley +37 more

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa167
N/A
0DataRank · unranked
39 citations

Holly LaDuca, Eric C. Polley, Chunling Hu, Nancy Niguidula, Hermela Shimelis +13 more

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score

Journal of Clinical Oncology(2021)10.1200/jco.20.01992
N/A
0DataRank · unranked
95 citations

Eric C. Polley, Steven N. Hart, Hongyan Huang, Chunling Hu, Rohan Gnanaolivu +37 more

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

Journal of Clinical Oncology(2021)10.1200/jco.21.00640
N/A
0DataRank · unranked
51 citations

Chunling Hu, Katherine L. Nathanson, Jeffrey N. Weitzel, David E. Goldgar, Peter Kraft +37 more

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0203
N/A
0DataRank · unranked
22 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants inATM,BRCA1,BRCA2,CHEK2, andPALB2

Journal of Clinical Oncology(2023)10.1200/jco.22.01239
N/A
0DataRank · unranked
175 citations

Nicholas Boddicker, Jie Na, Eric C. Polley, Chunling Hu, Steven N. Hart +31 more

Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

(2023)10.1158/1078-0432.c.6532509.v1
Top 100%
0DataRank
Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Figshare(2023)10.1158/1078-0432.22487391.v1
Top 100%
0DataRank
Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more